Skip to content

At the Telethon Kids Institute our researchers are searching for answers to improve the health and wellbeing of children and families affected by some of  the most devastating, complex and common diseases and issues.  At any one time we have more than 800 active research projects and 1400 staff and students that include laboratory scientists, clinicians, epidemiologists, bioinformaticians, statisticians, public health professionals and social scientists.

Our research is structured into Research Themes, programs of work and teams.  We are committed to collaboration and work together with other research organisations, clinicians, practitioners, policy makers, consumers and the community to understand the complexity of factors that impact on a child's health and wellbeing and the translation of research findings into action. We actively reward research excellence and offer a range of schemes to support our researchers.

In August 2018, we moved to a purpose-built facility located within Perth Children’s Hospital on the QEII Medical Centre campus - the largest centre of excellence in healthcare, research and education in the southern hemisphere. With a footprint across seven floors, our new home features more than 7000sqm of work space and 2000sqm of laboratories (including specialty suites, equipment rooms and freezer farms), as well as dedicated clinical suites and a cryogenics facility. Our co-location with the Perth Children’s Hospital will enhance our collaboration with clinicians, nursing staff and other allied health professionals, leading to better care, better treatments and better health and development outcomes for our children and young people.

We are an independent medical research institute based in Perth, Western Australia and affiliated with the State's major universities. Our research is  primarily funded through national and international competitive grants and generously supported by donors and governments.

June 2024

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

In Australian remote communities, First Nations children with otitis media (OM)-related hearing loss are disproportionately at risk of developmental delay and poor school performance, compared to those with normal hearing. Our objective was to compare OM-related hearing loss in children randomised to one of 2 pneumococcal conjugate vaccine (PCV) formulations.

Published research Ear Infections Immunisation Infectious Diseases Ear Health Subsite: END RHD
June 2024

Use of privacy-preserving record linkage to examine the dispensing of pharmaceutical benefits scheme medicines to pregnant women in Western Australia

Medications are commonly used during pregnancy to manage pre-existing conditions and conditions that arise during pregnancy. However, not all medications are safe to use in pregnancy. This study utilized privacy-preserving record linkage (PPRL) to examine medications dispensed under the national Pharmaceutical Benefits Scheme (PBS) to pregnant women in Western Australia (WA) overall and by medication safety category. 

Published research Child Disability Computational Biology Maternal health
May 2024

Murine bone-derived mesenchymal stem cells undergo molecular changes after a single passage in culture

The rarity of the mesenchymal stem cell (MSC) population poses a significant challenge for MSC research. Therefore, these cells are often expanded in vitro, prior to use. However, long-term culture has been shown to alter primary MSC properties.

Published research Leukaemia Translational Research Mitochondrial Research Gene Expression
May 2024

Human movement and environmental barriers shape the emergence of dengue

Understanding how emerging infectious diseases spread within and between countries is essential to contain future pandemics. Spread to new areas requires connectivity between one or more sources and a suitable local environment, but how these two factors interact at different stages of disease emergence remains largely unknown.

Published research Infectious Diseases Geospatial Health and Development Dengue fever

Associate Professor Glenn Pearson

Director of First Nations Strategy and Leadership

BA (Education) PhD Candidate

Professor Ben Jackson

Research Theme Head, Brain and Behaviour

BSc (Hons) PhD

Liz Davis

Head, Chronic & Severe Diseases Research Focus Area; Clinical Lead, Diabetes and Obesity Research


Professor Jane Pillow

Research Theme Head, Early Environment; Team Lead, Chronobiology

BMedSci (Dist) MBBS, PhD (Dist) FRACP